KLK3 and prostate cancer: Kallikrein-related peptidase 3 (KLK3) or prostate-specific antigen (PSA) is widely known as a prostate cancer marker (Lilja et al., 2008), which may also participate in prostate cancer development (Koistinen and Stenman, 2012).